(Q34153401)

31 July 2017

title

Hidden complexities in assessment of glycemic outcomes: are quality rankings aligned with treatment? (English)

1 reference

31 July 2017

Leonard M Pogach

1

1 reference

31 July 2017

Mangala Rajan

2

1 reference

31 July 2017

Miriam Maney

3

1 reference

31 July 2017

Chin-Lin Tseng

4

1 reference

31 July 2017

David C Aron

5

1 reference

31 July 2017

language of work or name

English

0 references

publication date

9 July 2010

1 reference

31 July 2017

1 reference

31 July 2017

volume

33

1 reference

31 July 2017

issue

10

1 reference

31 July 2017

page(s)

2133-2139

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

31 July 2017

copyright license

start time

28 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945148

Mitigating case mix factors by choice of glycemic control performance measure threshold

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945148

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945148

Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945148

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945148

Should mitigating comorbidities be considered in assessing healthcare plan performance in achieving optimal glycemic control?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945148

Advancing evidence-based care for diabetes: lessons from the Veterans Health Administration

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945148

Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945148

Pharmacy benefits management in the Veterans Health Administration: 1995 to 2003.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945148

Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945148

The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945148

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945148

One size does not fit all: the need for a continuous measure for glycemic control in diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945148

Impact of self-reported patient characteristics upon assessment of glycemic control in the Veterans Health Administration

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945148

Comparison of weighted performance measurement and dichotomous thresholds for glycemic control in the Veterans Health Administration

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945148

Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945148

Seasonal Patterns in Monthly Hemoglobin A1c Values

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945148

Contribution of hypoglycemia to medical care expenditures and short-term disability in employees with diabetes

28 October 2018

1 reference

12 December 2020

Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study

1 reference

12 December 2020

Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetes

1 reference

12 December 2020

Analytic bias among certified methods for the measurement of hemoglobin A1c: a cause for concern?

1 reference

12 December 2020

Identifiers

DOI

10.2337/DC09-1665

1 reference

31 July 2017

1 reference

31 July 2017

1 reference